And that is the key, for an investment.
The technology may be world class with a huge potential market.
But if the company can't execute, if a simple small trial is too much to achieve in a reasonable time, if they can't communicate with some degree of transparency, then people will take their capital and walk elsewhere.
'Was' = 'Is' in this case. I've seen nothing to indicate a change in the areas that matter.
GLTAH.
[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers, page-68
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
